COMBINATION TREATMNET OF BREAST CANCER PATIENTS DURING THE COVID-19 PANDEMIC

The aim of the study was to analyze the most significant studies representing the basic principles of diagnosis and treatment of patients with breast cancer (BC) during the CO VID -19 pandemic. Material and Methods. The search for relevant sources was carried out in PubMed, Cochrane Library, Web of Science systems, publications for 2019-2020 were studied, 48 of which were used to write this review. Results. During the CO VID -19 pandemic, it is necessary to suspend screening examinations for a certain period of time;patients with early and metastatic breast cancer should be transferred to outpatient treatment in the LU s located in their place of residence. Examinations and consultations of patients undergoing hormone therapy should be postponed or carried out using telemedicine technologies. Treatment of breast cancer patients during a pandemic should be carried out according to clinical guidelines and protocols, but minimizing the number of visits to the hospitals. Conclusion. The pandemic of the novel coronavirus infection (CO VID -19) is a serious problem for healthcare and professionals around the world. All treatment decisions must be based on risks and benefits in the context of each stage of the pandemic, on an individual basis and taking into account the preferences of patients.

Remodeling the cancer service in the context of the COVID-19 pandemic at the Federal research center of the 1st level

The article is devoted to the most relevant topic at present - the possibilities of providing full medical care to cancer patients in the context of the spread of the COVID-19 coronavirus pandemic. Cancer patients are the most vulnerable group, because they are at high risk from the position of immunosuppression, which is often combined with other risk factors for infection: old age, diabetes and cardiovascular diseases. Procrastination and delaying the start of antitumor therapy is unacceptable, since it inevitably leads to a deterioration of treatment results, an increase in one-year mortality and worsens the overall survival rate for malignant neoplasms. Thus, it is necessary to develop a set of measures that will allow all types of anti-cancer treatment to be carried out in parallel with anti-epidemic measures without losing the quality of treatment and preserving the safety of patients and medical personnel. Статья посвящена наиболее актуальной в настоящее время теме - возможностям оказания полноценной медицинской помощи онкологическим пациентам в условиях распространения пандемии коронавируса COVID-19. Онкологические пациенты являются наиболее уязвимым контингентом, поскольку находятся в зоне повышенного риска с позиции иммуносупрессии, которая зачастую сочетается с остальными факторами риска развития инфекции: пожилой возраст, наличие диабета и сердечно-сосудистых заболеваний. Промедление и затягивание сроков начала противоопухолевой терапии недопустимы, поскольку неизбежно ведут к ухудшению результатов лечения, повышению одногодичной летальности и ухудшают показатели общей выживаемости при злокачественных новообразованиях. Таким образом, необходимо разработать комплекс мер, которые позволят проводить все виды противоопухолевого лечения параллельно с противоэпидемическими мероприятиями без потери качества лечения и сохраняя безопасность для пациентов и медицинского персонала.